NATCOPHARMPharmaceuticals
Natco Pharma Ltd — PE Ratio & Valuation Analysis
₹974.20
+0.51%
Current P/E10.50xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E26.9x60.9% below avg
✅
66.9% Discount to Industry
NATCOPHARM P/E 10.50x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹105.26 | ₹903 | 8.6x |
| 2024 | ₹77.34 | ₹1387 | 17.9x |
| 2023 | ₹39.18 | ₹811 | 20.7x |
| 2022 | ₹9.32 | ₹562 | 60.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Natco Pharma Ltd Valuation
Natco Pharma Ltd (NATCOPHARM) currently trades at 10.50x earnings. The Pharmaceuticals sector average PE is 31.77x. NATCOPHARM is trading at a discount to peers — may indicate relative value. Historically, NATCOPHARM has traded at an average PE of 26.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
28.00%
Dividend Yield
0.66%
More on Natco Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.